Skip to content

#cell cycle

111 public questions tagged with this topic.

Which phase of the cell cycle is responsible for DNA replication?

Eukaryotic cell cycle comprises four organized stages orchestrated by cyclin-CDK oscillations, checkpoint kinases, and ubiquitin ligases ensuring faithful duplication. Gap1 G1 with cyclin D bound to CDK4 and CDK6 senses mitogen availability and growth factors via Ras-MAPK, phosphorylates retinoblastoma protein Rb releasing E2F transcription factors to produce cyclin E and replication factors. Entry into S phase, DNA synthesis phase, requires activation of pre-replication complexes assembled in late M and G1: origin recognition complex ORC binds origin DNA, Cdc6 and Cdt1 load MCM2-7 double hexamer licensing origins to ensure once per cycle. At G1/S transition, Dbf4-dependent kinase DDK and cyclin E/A-CDK2 phosphorylate MCM and Sld2/3 leading to recruitment of Cdc45, GINS forming active CMG helicase that unwinds parental duplex, RPA coats single stranded DNA, Pol alpha-primase synthesizes short RNA primers, Pol delta elongates lagging strand Okazaki fragments and Pol epsilon leading strand with PCNA sliding clamp increasing processivity and fidelity. Histone synthesis couples tightly. ATR-Chk1 monitors stalled forks preventing collapse. By end S phase genome duplicated from 2N to 4N preparing for G2 and mitosis.

Ref: Alberts et al., Molecular Biology of the Cell, 7th ed., Chapter 17: Cell Cycle S Phase and DNA Replication.

Which factor regulates the exit of cells from mitosis?

Exit from mitosis, defined transition from high CDK1 activity driving chromosome condensation and spindle assembly to low CDK state permitting G1 growth, is regulated primarily by anaphase-promoting complex/cyclosome APC/C ubiquitin ligase. After anaphase onset mediated by APC/C-Cdc20 degradation of securin and cyclin B, second wave of APC/C activity associated with coactivator Cdh1 becomes dominant as CDK1 inactivation allows Cdc14 and PP2A phosphatases to dephosphorylate Cdh1 permitting its binding. APC/C-Cdh1 polyubiquitinates remaining mitotic cyclin B, Polo-like kinase, Aurora kinases A and B, Cdc20 itself, and other regulators targeting them to 26S proteasome, ensuring CDK activity precipitously falls and remains low throughout G1. Decline permits phosphatases to dephosphorylate lamins for nuclear envelope reassembly, condensin dissociation for chromatin decondensation, Golgi reassembly, and licensing of replication origins via pre-RC formation. Without functional APC/C, cells arrest in late anaphase with high cyclin B, unable to reform nuclei, demonstrating central regulatory role governing mitotic exit irreversibly.

Ref: Sullivan & Morgan, Nature Rev Mol Cell Biol 2007, Mitotic Exit Control. Alberts 7th ed., Chapter 17.

Which of the following proteins is responsible for regulating the G1/S transition?

G1/S transition also known as restriction point in mammals marks commitment to DNA replication independent of extracellular mitogens thereafter. Regulation centers on retinoblastoma protein phosphorylation cascade. Mitogens induce cyclin D-CDK4/6 via Ras-MAPK pathway which initiates partial phosphorylation of Rb family proteins pRb, p107, p130 at specific serine sites, displacing histone deacetylases and allowing transcription of cyclin E gene driven by E2F1-3. Cyclin E then associates with CDK2, activated by CAK phosphorylation, forming cyclin E-CDK2 holoenzyme that hyperphosphorylates Rb at additional sites including Thr373, Ser612, causing complete dissociation and full E2F-dependent transcription of S-phase genes encoding cyclin A, MCM2-7, PCNA, DNA polymerase alpha and delta, thymidine kinase, and dihydrofolate reductase. Cyclin E-CDK2 also phosphorylates p27Kip1 Thr187 creating phosphodegron for SCF-Skp2 ubiquitination establishing positive feedback loop making transition switch-like irreversible. Loss of cyclin E arrests cells in G1 despite mitogen presence, proving essential role in governing G1/S progression. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Dulic et al., Cell 1992, Cyclin E-CDK2 at G1/S. Alberts 7th ed., Chapter 17, Restriction Point Control.

Which phase of the cell cycle is referred to as the quiescent phase?

Quiescent phase G0 represents reversible exit from cell cycle distinct from terminal differentiation and senescence, providing flexible pause aligning proliferation with physiological needs. Cells enter G0 from early G1 when mitogens withdraw, contact inhibition activates Hippo signaling with YAP nuclear exclusion, or nutrient deprivation suppresses mTORC1. Molecularly, cyclin D transcription declines, p27Kip1 and p130 Rb2 pocket protein accumulate, assembling DREAM complex with E2F4-DP1 repressing over 800 cell cycle genes including cyclin A, cyclin B, MCM helicases, and PCNA. Ribosomal RNA transcription by RNA polymerase I drops, reducing ribosome biogenesis and metabolic rate. Chromatin acquires repressive marks but retains plasticity. Upon re-addition of growth factors, Ras-ERK induces Myc and cyclin D, Skp2 mediated degradation reduces p27, DREAM disassembles, and cells re-enter G1. Lymphocytes, fibroblasts, hepatocytes, and stem cells exemplify G0. This reversible quiescence preserves proliferative capacity, prevents stem cell exhaustion, and matches tissue renewal to injury or demand, essential for longevity.

Ref: Alberts et al., Molecular Biology of the Cell, 7th ed., Chapter 17: G0 and Quiescence Regulation.

What happens if a proteasome inhibitor is added to cells in G2 phase?

Cell cycle progression relies heavily on ubiquitin-proteasome pathway to confer irreversibility to transitions via degradation of cyclins and CDK inhibitors. Proteasome comprises 20S catalytic core with chymotrypsin-like, trypsin-like, caspase-like activities and 19S regulatory particle recognizing polyubiquitinated proteins. Inhibitors such as MG132 peptide aldehyde, lactacystin, and clinically used bortezomib block catalytic threonine residues, causing accumulation of polyubiquitinated substrates. When applied in G2, proteasome blockade prevents degradation of SCF substrates like p21 and Wee1, APC/C substrates like cyclin A needed for S/G2 transition, and also blocks NF-kB inhibitor IkB turnover altering transcriptional programs. Consequence includes sustained Chk1 signaling from replication stress, stabilization of CDK inhibitors, and failure to degrade cyclin B after mitotic entry attempt, leading to persistent inhibitory phosphorylation on CDK1 and activation of G2/M checkpoint kinase Wee1. Cells therefore arrest at G2/M boundary with 4N DNA content, unable to satisfy APC/C requirements, eventually undergoing apoptosis if arrest prolonged, explaining chemotherapeutic efficacy.

Ref: Ciechanover, Nature Reviews Mol Cell Biol 2005, Proteasome and Cycle. Alberts 7th ed., Chapter 3.

In which phase of the cell cycle do cells prepare for mitosis?

G2 phase operates as final growth and quality control interval preparing cells materially and regulatory for mitosis. After completion of DNA replication in S phase, cells enter G2 where synthesis continues: transcription of genes encoding tubulin isotypes, gamma-tubulin ring complex proteins gamma-TuRC, pericentrin, Cep192, and microtubule-associated proteins rises to stockpile building blocks for spindle assembly. Centrosomes duplicated in S phase mature by acquisition of pericentriolar material becoming competent microtubule organizing centers. Organelles including Golgi apparatus and mitochondria expand through lipid synthesis and fusion events driven by mitofusins. Checkpoint kinase ATR activated by persistent RPA-coated single-stranded DNA and Chk1 maintain inhibitory Wee1-dependent Tyr15 phosphorylation on CDK1, holding cyclin B-CDK1 inactive while replication finishes. When replication and repair complete, Cdc25 phosphatases remove inhibitory marks, triggering feedback amplification that drives lamina breakdown, chromosome condensation, and Golgi unlinking. G2 thus ensures daughters inherit complete genome and sufficient organelle mass. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Alberts et al., Molecular Biology of the Cell, 7th ed., Chapter 17, G2 Phase Preparation for Mitosis.

The G2 phase is characterized by:

G2 phase is second gap phase dedicated to growth, quality surveillance, and accumulation of components required for mitosis. After S phase completes DNA synthesis, cells continue protein synthesis, particularly tubulin alpha/beta heterodimers and gamma-tubulin ring complex proteins for spindle assembly, histone variants H2AZ for chromatin stability, and membrane lipid synthesis for organelle expansion. Centrosomes duplicated during S phase mature in G2 by recruitment of pericentriolar material including pericentrin, Cep192, and Cdk5Rap2, acquiring ability to nucleate large astral microtubule arrays. Mitochondria undergo fusion driven by mitofusins to enhance ATP production for mitosis. Simultaneously DNA damage checkpoint kinase ATR monitors incomplete replication intermediates and stalled forks, maintaining cyclin B-CDK1 inactive via Wee1 mediated Tyr15 phosphorylation until genome fully duplicated. Transcription of mitotic cyclin B and Polo-like kinase rises, preparing wave of mitotic entry. G2 thus bridges synthesis and segregation, ensuring daughters inherit intact genome and sufficient cytoplasm. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Alberts et al., Molecular Biology of the Cell, 7th ed., Chapter 17, G2 as Preparation for M Phase.

What is the role of cyclins in cell cycle regulation?

Cyclins constitute regulatory subunits that impose temporal order on constitutively expressed but inactive cyclin-dependent kinases. In mammals, D-type cyclins respond to mitogens via Ras-MAPK induction, E-type governs G1/S boundary, A-type controls S and G2 progression, B-type drives mitosis. Binding of cyclin to CDK induces conformational change in T-loop exposing activation site for phosphorylation by CAK complex CDK7-cyclin H-Mat1, stabilizing fully active kinase competent for substrate phosphorylation. Substrate specificity derives from cyclin hydrophobic patch interacting with RXL motifs and subcellular localization. Cyclin D-CDK4/6 phosphorylates Rb pocket proteins, cyclin E-CDK2 phosphorylates p27 and Treslin, cyclin A-CDK2 phosphorylates ORC and Cdc6 to block re-licensing, cyclin B-CDK1 phosphorylates lamins, condensins, and nuclear pore proteins to disassemble interphase structures. Ubiquitin ligases SCF and APC/C confer switch-like inactivation by degrading cyclins at distinct cell cycle phases, producing oscillations. Without cyclin partner, CDKs exhibit negligible kinase activity, explaining functional dependency. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Morgan, The Cell Cycle: Principles of Control, Chapter 3: Cyclin-CDK Regulation. Alberts 7th ed., Chapter 17.

Which phase of the cell cycle is the most metabolically active?

Cellular metabolism is tightly coupled to cell cycle progression, with G1 phase exhibiting maximal biosynthetic activity to support doubling of mass before DNA replication. Upon growth factor binding, PI3K-Akt-mTORC1 pathway stimulates glucose uptake through GLUT1, increases glycolytic flux and pentose phosphate pathway for nucleotide precursors, enhances mitochondrial biogenesis via PGC1-alpha and mitochondrial transcription factor TFAM, and activates ribosome biogenesis through RNA polymerase I mediated rDNA transcription and S6K phosphorylation of ribosomal protein S6. Translation initiation factor eIF4E cap-binding protein synthesizes cyclins, CDKs, replication factors Cdt1, Cdc6, and histone chaperones. Lipid synthesis provides membrane for organelle growth, while amino acid transport sustains protein synthesis. By contrast, S phase devotes resources to dNTP synthesis, M phase shuts transcription, and G0 quiescent cells greatly reduce metabolic rate. Therefore G1 concentrates growth, accumulating tubulin, actin, and centrosome components monitored by size-sensing pathways. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Alberts et al., Molecular Biology of the Cell, 7th ed., Chapter 17: G1 Metabolism and Growth.

Which kinase is involved in regulating the initiation of DNA replication in S phase?

Initiation of DNA replication at licensed origins depends on two kinase families that separate licensing from firing. DDK kinase complex Dbf4-Cdc7 phosphorylates MCM2-7 helicase at N-terminal serine-threonine clusters, promoting Cdc45 recruitment. Second trigger is S-phase CDK activity supplied by cyclin E-CDK2 that peaks at G1/S border and cyclin A-CDK2 that sustains activity into S phase. Cyclin E-CDK2 phosphorylates Treslin/TICRR at threonine 969, MTBP, RecQL4, and orthologs of yeast Sld2 and Sld3, enabling their binding to BRCT repeats of TopBP1 and assembly of Cdc45-MCM-GINS active helicase known as CMG that unwinds duplex DNA and recruits DNA polymerases alpha, delta, epsilon, and Ctf4 for leading and lagging strand synthesis. CDK2 also phosphorylates licensing factors Cdc6 and Cdt1 for nuclear export and SCF-dependent proteolysis to prevent re-licensing. CDK4/6 acts indirectly in early G1 to induce cyclin E transcription via Rb phosphorylation. Inhibition of CDK2 blocks origin firing without affecting cyclin D accumulation. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Labib, Genes & Dev 2010, Origin Activation. Limas & Cook, Genes & Dev 2019, CDK Roles S Phase.

Which protein is degraded by APC to trigger chromosome separation?

Chromatid cohesion must be maintained until synchronous separation at anaphase, requiring protection against premature cleavage. Securin, also called pituitary tumor transforming gene PTTG, functions as dual inhibitor and chaperone of separase. Securin sequence contains D-box and KEN motifs for APC/C recognition and binds separase HEAT repeats, occluding catalytic triad. Accumulation during S and G2 concentrates at centromeres. At metaphase, APC/C-Cdc20 polyubiquitinates securin, triggering rapid proteasomal degradation within five to ten minutes, concentration dropping precipitously. Simultaneously cyclin B destruction inactivates CDK1 that also phosphorylates separase inhibitory sites, fully unleashing protease. Liberated separase translocates to chromosomes and cleaves Rad21/Scc1 kleisin at conserved EXXR motifs after glutamate, generating N- and C-terminal fragments unable to maintain ring closure. This opens cohesin, allowing kinetochore microtubules to pull sisters to opposite poles. Expression of non-degradable securin mutant with mutated D-box prevents cohesion loss and arrests cells in metaphase with intact cohesion. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Uhlmann et al., Nature 1999, Separase Cohesin Cleavage. Alberts 7th ed., Chapter 17, Securin.

Wee1 kinase inhibition in G2 phase leads to:

G2 progression is gated by inhibitory phosphorylation of master mitotic kinase CDK1 that prevents premature mitotic entry while last preparations complete. Nuclear kinase Wee1 and membrane-associated Myt1 phosphorylate CDK1 subunit within cyclin B-CDK1 complex at Tyr15 and Thr14 within ATP-binding loop, rendering kinase catalytically inactive despite abundant cyclin B synthesized during G2, allowing centrosome maturation, Golgi segregation, and DNA repair synthesis to proceed. At G2/M border, dual-specificity phosphatases Cdc25A/B/C remove these phosphates, causing explosive autoamplification where CDK1 phosphorylates Cdc25 to activate it and phosphorylates Wee1 to inhibit it. Pharmacologic inhibition or siRNA depletion of Wee1 eliminates inhibitory phosphate, leading to immediate activation of cyclin B-CDK1 before replication fully completed or damage repaired, driving cells into mitosis with under-replicated DNA, premature chromosome condensation, pulverization, and activation of mitotic catastrophe program. This vulnerability underlies therapy where Wee1 inhibitors enhance genotoxic chemotherapy efficacy in p53-deficient cancers. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.

Ref: Harper & Elledge, Mol Biol Cell 2007, Wee1 Control. Alberts 7th ed., Chapter 17, CDK1 Regulation.